H.C. Wainwright Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
Viking Therapeutics initiated with an Outperform at Scotiabank
Scotiabank initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 price target Maximize Your Portfolio with Data ...
Insider Monkey14d
Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’
In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against the other stocks. Jim Cramer, the host of Mad Money, recently expressed his concerns ...
ETF Daily News17d
Viking Therapeutics (VKTX) Projected to Post Earnings on Wednesday
HC Wainwright reiterated a “buy” rating and set a $102.00 target price on shares of Viking Therapeutics in a report on Friday, January 17th. B. Riley started coverage on shares of Viking ...
MarketWatch18d
What’s next for hot biotech stock Viking Therapeutics? Here’s how the company can scale up.
Viking Therapeutics Inc.’s stock jumped 3% Tuesday, after a bullish note from Oppenheimer highlighted the company’s promising obesity-drug program and its potential appeal to a deep-pocketed ...
Seeking Alpha22d
Viking Therapeutics: Investors Meeting Reality Of The Obesity Market
It has been a little more than two months since my last Viking Therapeutics, Inc. (NASDAQ:VKTX) article, where I highlighted their promising pipeline for obesity, NASH/MASH, and X-ALD programs ...
Yahoo Finance24d
Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know
The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...
Yahoo Finance24d
Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know
The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily gain of ...
Yahoo24d
Trump’s patriotic new White House logo is painfully unsubtle
To commemorate Donald Trump's return to office, the White House has released a new logo design that bucks the trend of previous administrations. A dark twist on the light and breezy appeal of ...
Seeking Alpha24d
Viking Therapeutics: The Turning Point Is Not Here Yet
The upstart, clinical stage biotech company Viking Therapeutics, Inc. (NASDAQ:VKTX), which is attempting to disrupt their market leadership has also suffered from a protracted hangover ...
Investing24d
Viking Therapeutics stock gains traction with standout dual-agonist VK2735 efficacy data
Tuesday, Viking Therapeutics (NASDAQ:VKTX), currently trading at $32.65, remained in focus as H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating with a price target of $102.00. According ...